[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Cancer/Tumor Profiling and Pathways Market - Global Outlook and Forecast 2021-2027

April 2021 | 94 pages | ID: CB4B28477B5BEN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Cancer/Tumor Profiling and Pathways in Global, including the following market information:

Global Cancer/Tumor Profiling and Pathways Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Cancer/Tumor Profiling and Pathways market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cancer/Tumor Profiling and Pathways companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cancer/Tumor Profiling and Pathways Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Cancer/Tumor Profiling and Pathways Market Segment Percentages, By Type, 2020 (%)
  • Immunoassays
  • Next Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • In-Situ Hybridization (ISH)
  • Microarrays
  • Mass Spectrometry
  • Others
China Cancer/Tumor Profiling and Pathways Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Cancer/Tumor Profiling and Pathways Market Segment Percentages, By Application, 2020 (%)
  • Research
  • Clinical
Global Cancer/Tumor Profiling and Pathways Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Cancer/Tumor Profiling and Pathways Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Total Cancer/Tumor Profiling and Pathways Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Cancer/Tumor Profiling and Pathways Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:
  • Illumina, Inc. (US)
  • QIAGEN N.V. (Germany)
  • NeoGenomics Laboratories, Inc. (US)
  • HTG Molecular Diagnostics, Inc. (US)
  • Sysmex Corporation (Japan)
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Cancer/Tumor Profiling and Pathways Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Cancer/Tumor Profiling and Pathways Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CANCER/TUMOR PROFILING AND PATHWAYS OVERALL MARKET SIZE

2.1 Global Cancer/Tumor Profiling and Pathways Market Size: 2021 VS 2027
2.2 Global Cancer/Tumor Profiling and Pathways Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Cancer/Tumor Profiling and Pathways Players in Global Market
3.2 Top Global Cancer/Tumor Profiling and Pathways Companies Ranked by Revenue
3.3 Global Cancer/Tumor Profiling and Pathways Revenue by Companies
3.4 Top 3 and Top 5 Cancer/Tumor Profiling and Pathways Companies in Global Market, by Revenue in 2020
3.5 Global Companies Cancer/Tumor Profiling and Pathways Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer/Tumor Profiling and Pathways Players in Global Market
  3.6.1 List of Global Tier 1 Cancer/Tumor Profiling and Pathways Companies
  3.6.2 List of Global Tier 2 and Tier 3 Cancer/Tumor Profiling and Pathways Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Cancer/Tumor Profiling and Pathways Market Size Markets, 2021 & 2027
  4.1.2 Immunoassays
  4.1.3 Next Generation Sequencing (NGS)
  4.1.4 Polymerase Chain Reaction (PCR)
  4.1.5 In-Situ Hybridization (ISH)
  4.1.6 Microarrays
  4.1.7 Mass Spectrometry
  4.1.8 Others
4.2 By Type - Global Cancer/Tumor Profiling and Pathways Revenue & Forecasts
  4.2.1 By Type - Global Cancer/Tumor Profiling and Pathways Revenue, 2016-2021
  4.2.2 By Type - Global Cancer/Tumor Profiling and Pathways Revenue, 2022-2027
  4.2.3 By Type - Global Cancer/Tumor Profiling and Pathways Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Cancer/Tumor Profiling and Pathways Market Size, 2021 & 2027
  5.1.2 Research
  5.1.3 Clinical
5.2 By Application - Global Cancer/Tumor Profiling and Pathways Revenue & Forecasts
  5.2.1 By Application - Global Cancer/Tumor Profiling and Pathways Revenue, 2016-2021
  5.2.2 By Application - Global Cancer/Tumor Profiling and Pathways Revenue, 2022-2027
  5.2.3 By Application - Global Cancer/Tumor Profiling and Pathways Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Cancer/Tumor Profiling and Pathways Market Size, 2021 & 2027
6.2 By Region - Global Cancer/Tumor Profiling and Pathways Revenue & Forecasts
  6.2.1 By Region - Global Cancer/Tumor Profiling and Pathways Revenue, 2016-2021
  6.2.2 By Region - Global Cancer/Tumor Profiling and Pathways Revenue, 2022-2027
  6.2.3 By Region - Global Cancer/Tumor Profiling and Pathways Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Cancer/Tumor Profiling and Pathways Revenue, 2016-2027
  6.3.2 US Cancer/Tumor Profiling and Pathways Market Size, 2016-2027
  6.3.3 Canada Cancer/Tumor Profiling and Pathways Market Size, 2016-2027
  6.3.4 Mexico Cancer/Tumor Profiling and Pathways Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Cancer/Tumor Profiling and Pathways Revenue, 2016-2027
  6.4.2 Germany Cancer/Tumor Profiling and Pathways Market Size, 2016-2027
  6.4.3 France Cancer/Tumor Profiling and Pathways Market Size, 2016-2027
  6.4.4 U.K. Cancer/Tumor Profiling and Pathways Market Size, 2016-2027
  6.4.5 Italy Cancer/Tumor Profiling and Pathways Market Size, 2016-2027
  6.4.6 Russia Cancer/Tumor Profiling and Pathways Market Size, 2016-2027
  6.4.7 Nordic Countries Cancer/Tumor Profiling and Pathways Market Size, 2016-2027
  6.4.8 Benelux Cancer/Tumor Profiling and Pathways Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Cancer/Tumor Profiling and Pathways Revenue, 2016-2027
  6.5.2 China Cancer/Tumor Profiling and Pathways Market Size, 2016-2027
  6.5.3 Japan Cancer/Tumor Profiling and Pathways Market Size, 2016-2027
  6.5.4 South Korea Cancer/Tumor Profiling and Pathways Market Size, 2016-2027
  6.5.5 Southeast Asia Cancer/Tumor Profiling and Pathways Market Size, 2016-2027
  6.5.6 India Cancer/Tumor Profiling and Pathways Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Cancer/Tumor Profiling and Pathways Revenue, 2016-2027
  6.6.2 Brazil Cancer/Tumor Profiling and Pathways Market Size, 2016-2027
  6.6.3 Argentina Cancer/Tumor Profiling and Pathways Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Cancer/Tumor Profiling and Pathways Revenue, 2016-2027
  6.7.2 Turkey Cancer/Tumor Profiling and Pathways Market Size, 2016-2027
  6.7.3 Israel Cancer/Tumor Profiling and Pathways Market Size, 2016-2027
  6.7.4 Saudi Arabia Cancer/Tumor Profiling and Pathways Market Size, 2016-2027
  6.7.5 UAE Cancer/Tumor Profiling and Pathways Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Illumina, Inc. (US)
  7.1.1 Illumina, Inc. (US) Corporate Summary
  7.1.2 Illumina, Inc. (US) Business Overview
  7.1.3 Illumina, Inc. (US) Cancer/Tumor Profiling and Pathways Major Product Offerings
  7.1.4 Illumina, Inc. (US) Cancer/Tumor Profiling and Pathways Revenue in Global (2016-2021)
  7.1.5 Illumina, Inc. (US) Key News
7.2 QIAGEN N.V. (Germany)
  7.2.1 QIAGEN N.V. (Germany) Corporate Summary
  7.2.2 QIAGEN N.V. (Germany) Business Overview
  7.2.3 QIAGEN N.V. (Germany) Cancer/Tumor Profiling and Pathways Major Product Offerings
  7.2.4 QIAGEN N.V. (Germany) Cancer/Tumor Profiling and Pathways Revenue in Global (2016-2021)
  7.2.5 QIAGEN N.V. (Germany) Key News
7.3 NeoGenomics Laboratories, Inc. (US)
  7.3.1 NeoGenomics Laboratories, Inc. (US) Corporate Summary
  7.3.2 NeoGenomics Laboratories, Inc. (US) Business Overview
  7.3.3 NeoGenomics Laboratories, Inc. (US) Cancer/Tumor Profiling and Pathways Major Product Offerings
  7.3.4 NeoGenomics Laboratories, Inc. (US) Cancer/Tumor Profiling and Pathways Revenue in Global (2016-2021)
  7.3.5 NeoGenomics Laboratories, Inc. (US) Key News
7.4 HTG Molecular Diagnostics, Inc. (US)
  7.4.1 HTG Molecular Diagnostics, Inc. (US) Corporate Summary
  7.4.2 HTG Molecular Diagnostics, Inc. (US) Business Overview
  7.4.3 HTG Molecular Diagnostics, Inc. (US) Cancer/Tumor Profiling and Pathways Major Product Offerings
  7.4.4 HTG Molecular Diagnostics, Inc. (US) Cancer/Tumor Profiling and Pathways Revenue in Global (2016-2021)
  7.4.5 HTG Molecular Diagnostics, Inc. (US) Key News
7.5 Sysmex Corporation (Japan)
  7.5.1 Sysmex Corporation (Japan) Corporate Summary
  7.5.2 Sysmex Corporation (Japan) Business Overview
  7.5.3 Sysmex Corporation (Japan) Cancer/Tumor Profiling and Pathways Major Product Offerings
  7.5.4 Sysmex Corporation (Japan) Cancer/Tumor Profiling and Pathways Revenue in Global (2016-2021)
  7.5.5 Sysmex Corporation (Japan) Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES

Table 1. Cancer/Tumor Profiling and Pathways Market Opportunities & Trends in Global Market
Table 2. Cancer/Tumor Profiling and Pathways Market Drivers in Global Market
Table 3. Cancer/Tumor Profiling and Pathways Market Restraints in Global Market
Table 4. Key Players of Cancer/Tumor Profiling and Pathways in Global Market
Table 5. Top Cancer/Tumor Profiling and Pathways Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Cancer/Tumor Profiling and Pathways Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Cancer/Tumor Profiling and Pathways Revenue Share by Companies, 2016-2021
Table 8. Global Companies Cancer/Tumor Profiling and Pathways Product Type
Table 9. List of Global Tier 1 Cancer/Tumor Profiling and Pathways Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer/Tumor Profiling and Pathways Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Cancer/Tumor Profiling and Pathways Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Cancer/Tumor Profiling and Pathways Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Cancer/Tumor Profiling and Pathways Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Cancer/Tumor Profiling and Pathways Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Cancer/Tumor Profiling and Pathways Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Cancer/Tumor Profiling and Pathways Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2022-2027
Table 30. Illumina, Inc. (US) Corporate Summary
Table 31. Illumina, Inc. (US) Cancer/Tumor Profiling and Pathways Product Offerings
Table 32. Illumina, Inc. (US) Cancer/Tumor Profiling and Pathways Revenue (US$, Mn), (2016-2021)
Table 33. QIAGEN N.V. (Germany) Corporate Summary
Table 34. QIAGEN N.V. (Germany) Cancer/Tumor Profiling and Pathways Product Offerings
Table 35. QIAGEN N.V. (Germany) Cancer/Tumor Profiling and Pathways Revenue (US$, Mn), (2016-2021)
Table 36. NeoGenomics Laboratories, Inc. (US) Corporate Summary
Table 37. NeoGenomics Laboratories, Inc. (US) Cancer/Tumor Profiling and Pathways Product Offerings
Table 38. NeoGenomics Laboratories, Inc. (US) Cancer/Tumor Profiling and Pathways Revenue (US$, Mn), (2016-2021)
Table 39. HTG Molecular Diagnostics, Inc. (US) Corporate Summary
Table 40. HTG Molecular Diagnostics, Inc. (US) Cancer/Tumor Profiling and Pathways Product Offerings
Table 41. HTG Molecular Diagnostics, Inc. (US) Cancer/Tumor Profiling and Pathways Revenue (US$, Mn), (2016-2021)
Table 42. Sysmex Corporation (Japan) Corporate Summary
Table 43. Sysmex Corporation (Japan) Cancer/Tumor Profiling and Pathways Product Offerings
Table 44. Sysmex Corporation (Japan) Cancer/Tumor Profiling and Pathways Revenue (US$, Mn), (2016-2021)

LIST OF FIGURES

Figure 1. Cancer/Tumor Profiling and Pathways Segment by Type
Figure 2. Cancer/Tumor Profiling and Pathways Segment by Application
Figure 3. Global Cancer/Tumor Profiling and Pathways Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Cancer/Tumor Profiling and Pathways Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Cancer/Tumor Profiling and Pathways Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer/Tumor Profiling and Pathways Revenue in 2020
Figure 8. By Type - Global Cancer/Tumor Profiling and Pathways Revenue Market Share, 2016-2027
Figure 9. By Application - Global Cancer/Tumor Profiling and Pathways Revenue Market Share, 2016-2027
Figure 10. By Region - Global Cancer/Tumor Profiling and Pathways Revenue Market Share, 2016-2027
Figure 11. By Country - North America Cancer/Tumor Profiling and Pathways Revenue Market Share, 2016-2027
Figure 12. US Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Cancer/Tumor Profiling and Pathways Revenue Market Share, 2016-2027
Figure 16. Germany Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2016-2027
Figure 17. France Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Cancer/Tumor Profiling and Pathways Revenue Market Share, 2016-2027
Figure 24. China Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2016-2027
Figure 28. India Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Cancer/Tumor Profiling and Pathways Revenue Market Share, 2016-2027
Figure 30. Brazil Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Cancer/Tumor Profiling and Pathways Revenue Market Share, 2016-2027
Figure 33. Turkey Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Cancer/Tumor Profiling and Pathways Revenue, (US$, Mn), 2016-2027
Figure 37. Illumina, Inc. (US) Cancer/Tumor Profiling and Pathways Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. QIAGEN N.V. (Germany) Cancer/Tumor Profiling and Pathways Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. NeoGenomics Laboratories, Inc. (US) Cancer/Tumor Profiling and Pathways Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. HTG Molecular Diagnostics, Inc. (US) Cancer/Tumor Profiling and Pathways Revenue Year Over Year Growth (US$, Mn) & (2016-2021)


More Publications